Old Web
English
Sign In
Acemap
>
authorDetail
>
Benjamin Koziner
Benjamin Koziner
University of Texas MD Anderson Cancer Center
Oblimersen
Chronic lymphocytic leukemia
Pathology
Medicine
Cyclophosphamide
3
Papers
423
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pooled safety analysis of oblimersen alone or with fludarabine and cyclophosphamide in patients with advanced chronic lymphocytic leukemia
2016
Journal of Clinical Oncology
Benjamin Koziner
S OBrien
Thomas E. Boyd
Loree Larratt
Joseph O. Moore
Asher Chanan-Khan
Show All
Source
Cite
Save
Citations (1)
5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
2009
Journal of Clinical Oncology
Susan OBrien
Joseph O. Moore
Thomas E. Boyd
Loree Larratt
Aleksander B. Skotnicki
Benjamin Koziner
Asher Chanan-Khan
John F. Seymour
John G. Gribben
Loretta M. Itri
Kanti R. Rai
Show All
Source
Cite
Save
Citations (139)
Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
2007
Journal of Clinical Oncology
Susan O'Brien
Joseph O. Moore
Thomas E. Boyd
Loree Larratt
Aleksander B. Skotnicki
Benjamin Koziner
Asher Chanan-Khan
John F. Seymour
R. Gregory Bociek
Steve Pavletic
Kanti R. Rai
Show All
Source
Cite
Save
Citations (283)
1